Skip to main content
. 2020 Aug 25;11:1942. doi: 10.3389/fimmu.2020.01942

FIGURE 2.

FIGURE 2

(A) Before the first administration of canakinumab, the chest X-ray shows interstitial changes, ground glass opacities, and multifocal and bilateral effusions. (B) After second administration, the chest X-ray shows the extensive bilateral opacities and bilateral effusions, concomitant to bacterial superinfection.